Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils

Clinical trial NCT06240767 · UNKNOWN

Trial details

NCT number: NCT06240767
Sponsor: Wuxi People's Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult Advanced Cancer

Start date: 2023-11-01
Primary completion: 2025-06-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.